Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02958072Not ApplicableCompleted

LeucoPatch in Malleoli Ulcer Study

Role: collaborator

NCT01454401Not ApplicableCompleted

LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers

Role: lead

NCT03997526Terminated

3C Patch® Medicare Claims Study

Role: lead

NCT03370055Not ApplicableWithdrawn

LeucoPatch® in Nonhealing Wounds With Exposed Bone or Tendon Study

Role: collaborator

All 4 trials loaded